Market Place
Sourcing Support
Novo Nordisk A/S: Share Repurchase Programme
27 Apr 2026 //
GLOBENEWSWIRE
Lilly`s Obesity Pill Shows Modest Performance In Second Week
24 Apr 2026 //
REUTERS HEALTHCARE
MHRA Approves 48-Hour Controlled-Temp Storage for Wegovy
23 Apr 2026 //
PHARMIWEB
New Funding Paves Way for Better Diagnostics, Biosolutions
23 Apr 2026 //
GLOBENEWSWIRE
Novo Nordisk A/S - share repurchase programme
20 Apr 2026 //
GLOBENEWSWIRE
Novo Nordisk weight-loss drug shows liver benefits in mouse study
16 Apr 2026 //
REUTERS
Pharma Gears Up For Q1 Earnings With Focus On Deals
14 Apr 2026 //
BIOSPACE
Novo Nordisk A/S: Share Repurchase Programme
13 Apr 2026 //
GLOBENEWSWIRE
Novo`s GLP-1 Pioneer Retires; Obesity Leader Joins Boehringer
10 Apr 2026 //
ENDPOINTS NEWS
Novo Nordisk A/S: Share Repurchase Programme
07 Apr 2026 //
GLOBENEWSWIRE
UK Cost Watchdog Clears Novo`s Wegovy For Cardio Risk Reduction
01 Apr 2026 //
FIERCE PHARMA
Novo Nordisk Slashes Ozempic, Wegovy Prices by Up to 48% in India
31 Mar 2026 //
ECONOMICTIMES
Novo Nordisk Cuts 400 Roles At Troubled Bloomington Site
31 Mar 2026 //
FIERCE PHARMA
Weight Watchers Introduces Competitive Self-Pay Wegovy Pricing
31 Mar 2026 //
GLOBENEWSWIRE
Novo Nordisk A/S: Share Repurchase Programme
30 Mar 2026 //
GLOBENEWSWIRE
Articles of Association for Novo Nordisk 2026
27 Mar 2026 //
GLOBENEWSWIRE
Resolutions from the Annual General Meeting of Novo Nordisk A/S
26 Mar 2026 //
GLOBENEWSWIRE
Novo Faces Access Challenges Despite Strong Wegovy Launch
25 Mar 2026 //
BIOSPACE
Novo Nordisk A/S: Share Repurchase Programme
23 Mar 2026 //
GLOBENEWSWIRE
Novo Nordisk A/S Launches Share Buyback Program
16 Mar 2026 //
GLOBENEWSWIRE
Patent Expirations Push Biopharma Industry Toward A Tougher 2026
13 Mar 2026 //
FIERCE PHARMA
Novo’ Assets Fell 34% in 2025 As Its Namesake Drugmaker Struggled
13 Mar 2026 //
BIOSPACE
Novo Holdings Announces 2025 Annual Results
12 Mar 2026 //
GLOBENEWSWIRE
Novo Nordisk Boosts Semaglutide Over Eli Lilly In Market Share
09 Mar 2026 //
ECONOMICTIMES
Hims & Hers Announces Strategic Shift For US Weight Loss Business
09 Mar 2026 //
BUSSINESSWIRE
Novo Nordisk Ends GLP-1 Dispute With Hims & Hers
09 Mar 2026 //
BIOSPACE
Novo Nordisk Launches Share Repurchase Program
09 Mar 2026 //
GLOBENEWSWIRE
Keytruda Hangs On To Best Seller Crown As Glp-1s Gain Ground
04 Mar 2026 //
BIOSPACE
Novo Charts $500M Ireland Upgrade To Produce Wegovy Pill
03 Mar 2026 //
FIERCE PHARMA
Novo Allocates $506M To Convert Irish Plant For Oral Wegovy
02 Mar 2026 //
BIOSPACE
Novo Nordisk Expands Athlone, Ireland Facility By Over 400M Euros
02 Mar 2026 //
GLOBENEWSWIRE
Novo Nordisk A/S: Share Repurchase Programme
02 Mar 2026 //
GLOBENEWSWIRE
Novo Nordisk Elects Employee Representatives To Board
02 Mar 2026 //
GLOBENEWSWIRE
Novo Plans List Price Reduction For Semaglutide Drugs In `27
24 Feb 2026 //
FIERCE PHARMA
Novo Nordisk A/S: Share Repurchase Programme
23 Feb 2026 //
GLOBENEWSWIRE
Madrigal embraces Novo Competition as MASH Drug Gains Steam
18 Feb 2026 //
FIERCE PHARMA
EU Approves Enhanced Wegovy for Obesity in Adults
17 Feb 2026 //
GLOBENEWSWIRE
Novo Nordisk A/S - Share Repurchase Programme
16 Feb 2026 //
GLOBENEWSWIRE
Novo Nordisk Board Members And Executives Trade Company Shares
11 Feb 2026 //
GLOBENEWSWIRE
Novo, Lilly Earnings Ignite Weight Loss Drama, Gene Therapy Buzz
11 Feb 2026 //
BIOSPACE
Novo Nordisk Board Members And Executives Trade Company Shares
10 Feb 2026 //
GLOBENEWSWIRE
Novo Nordisk Sues Hims & Hers Over Counterfeit Wegovy®
09 Feb 2026 //
GLOBENEWSWIRE
Novo Nordisk A/S - Share Repurchase Programme
09 Feb 2026 //
GLOBENEWSWIRE
Novo`s 1St Super Bowl Ad Taps Celebs To Tout Wegovy Pill
06 Feb 2026 //
FIERCE PHARMA
Novo Nordisk Launches Wegovy® Pill For Consumers At Major Event
06 Feb 2026 //
PR NEWSWIRE
US Government Launches Trumprx Drug Purchasing Portal
06 Feb 2026 //
FIERCE PHARMA
Novo Nordisk Fires Back at Hims` $49 Semaglutide Pill
05 Feb 2026 //
GLOBENEWSWIRE
Novo Nordisk Flags Concerns Over Pharmazee GLP-1 Scripts
05 Feb 2026 //
GLOBENEWSWIRE
Novo Nordisk Board, Executives, and Associates Trade Shares
05 Feb 2026 //
GLOBENEWSWIRE
Novo Nordisk Files Annual Report With The SEC
04 Feb 2026 //
GLOBENEWSWIRE
Novo Nordisk`s Sales Rise 10% To DKK 309.1B In 2025
03 Feb 2026 //
GLOBENEWSWIRE
Novo Nordisk Releases 2026 Sales And Operating Profit Outlook
03 Feb 2026 //
GLOBENEWSWIRE
Novo Slides 14% On Early Q4 Results Forecasting 2026 Sales Drop
03 Feb 2026 //
BIOSPACE
Novo`s next-gen obesity drug outperforms Wegovy in diabetes trial
02 Feb 2026 //
REUTERS
Obesity Market Sales Tightens as Novo & Lilly Enter New Era
02 Feb 2026 //
REUTERS
Novo Nordisk A/S Appoints New Board Member
31 Jan 2026 //
GLOBENEWSWIRE
Novo Wins Support From Big Business In Its Ongoing IRA Challenge
29 Jan 2026 //
FIERCE PHARMA
Roche Plans To Go Toe-To-Toe With Novo, Lilly In Obesity
29 Jan 2026 //
BIOSPACE
With 200 JPM Meetings, Novo BD Head Seeks Out The Next Metsera
27 Jan 2026 //
FIERCE BIOTECH
Wegovy Pill Launch Wows With Strong Early Uptake: Analysts
23 Jan 2026 //
FIERCE PHARMA
